Current Ratio in % of Transcode Therapeutics, Inc. from Q1 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Transcode Therapeutics, Inc. quarterly Current Ratio history and change rate from Q1 2022 to Q3 2025.
  • Transcode Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 338 %, a 111% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Transcode Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 338 +178 +111% 30 Sep 2025
Q2 2025 350 +187 +115% 30 Jun 2025
Q1 2025 254 +88.2 +53.1% 31 Mar 2025
Q4 2024 194 +65.9 +51.6% 31 Dec 2024
Q3 2024 160 +22.6 +16.4% 30 Sep 2024
Q2 2024 163 -1.96 -1.19% 30 Jun 2024
Q1 2024 166 -77.3 -31.8% 31 Mar 2024
Q4 2023 128 -313 -71% 31 Dec 2023
Q3 2023 137 -539 -79.7% 30 Sep 2023
Q2 2023 165 -803 -83% 30 Jun 2023
Q1 2023 243 -583 -70.6% 31 Mar 2023
Q4 2022 440 31 Dec 2022
Q3 2022 677 30 Sep 2022
Q2 2022 968 30 Jun 2022
Q1 2022 826 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.